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Abstract 
Large-scale emergencies, like the ongoing COVID-19 pandemic, demonstrate pervasive effects across 
multiple sectors. There is a continually growing body of evidence demonstrating gender and sex 
differences in COVID-19 disease, as well as its health, social, and economic impacts. While online 
resources have worked to compile this evidence, there is a need to evaluate and synthesize the available 
gender- and sex-disaggregated data related to COVID-19. This literature review will systematically assess 
and compile current literature and evidence from different disciplines. We will include peer reviewed 
articles, clinical studies and reports, and relevant working papers using secondary data analyses and 
primary research methodologies. We will synthesize and describe the evidence on multiple outcomes of 
interest, including gender and sex differences in mortality, severity, treatment outcomes, exposure to 
violence, mental health and psychosocial support needs, and economic insecurity with COVID-19. These 
results can be used to inform policy, identify research gaps, and support recommendations for priority 
interventions.  
BACKGROUND 
Lessons from past disease outbreaks, such as Zika and Ebola, illustrate the importance of incorporating a 
gender lens into disease response and prevention (1, 2). Public health emergencies can exacerbate existing 
inequalities and reveal how gender influences the health system and group vulnerabilities related to 
mortality, exposure, and access to care (3-5). There continues to be a missing gender lens in evidence and 
 
response related to the ongoing COVID-19 pandemic. Gender and sex differences can emerge in both 
direct consequences of disease (e.g., death, severity, and treatment outcomes) and indirect consequences 
due to disease response (e.g., loss of income, exposure to violence, and difficulty accessing resources). 
Understanding how these differ by gender and sex is essential in addressing needs and creating equitable 
interventions. To this end, it is vital to ensure collection and accessibility of gender- and sex-
disaggregated data. Of the available data and literature found across multiple sectors (i.e., health, social, 
and economic), no one has collectively synthesized this body of evidence on the impacts of COVID-19 by 
gender and sex.   
Research is rapidly emerging on sex and gender differences in relation to COVID-19. Global Health 
50/50 is one resource tracking COVID-19 sex-disaggregated data, including mortality and diagnosed 
cases. While differences in prevalence appear to vary, a higher number of deaths from COVID-19 are 
occurring in males (6). This difference in mortality may represent sex-based biological differences or 
gendered differences (e.g., smoking practices) (3). Evidence is still developing on how hospitalizations, 
severity of disease, and treatment outcomes with COVID-19 differ by sex and gender. Data from Wuhan 
has suggested that men are at higher risk for severe cases with COVID-19 (7). Empirical evidence has 
also previously demonstrated that treatment outcomes with immunotherapies differ by sex, with 
immunotherapy notably being investigated in treatment of COVID-19 as it has been effective in 
managing infections like SARS-CoV and MERS-CoV in the past (8, 9).  
On the other hand, women are at risk of frequent exposure as they make up approximately 70% of the 
frontline health and social sector workforce (3-5, 10-12). Women providing informal care within 
households may face additional exposure risk when caring for ill or elderly family members (3, 12, 13). 
School closures are also expected to impact informal caregivers, where this additional responsibility may 
result in a loss of income and work outside the home (3). Household economic opportunity can be limited 
by travel restrictions and stay-at-home orders. As women are disproportionately represented in lower-
paid, part-time, and informal work, loss of income may differ by gender due to these restrictive measures 
(3, 12-15).  
Instances of violence, such as gender-based violence (GBV) or intimate partner violence (IPV), typically 
increase during and after emergencies (3, 5, 13, 17). Cases rise as people experience heightened stress 
related to economic security and safety, in combination with being isolated due to quarantine or stay-at-
home orders (15). Reports of IPV have increased in several countries since responding to COVID-19 (5). 
France has reported a 30% increase in domestic violence cases since initiating lockdown on March 17th 
(15), and during the month of February cases in China were three times higher compared to the prior year 
(18). People experiencing violence will have fewer options for support and additional challenges in access 
due to COVID-19 restrictions (15, 19). Groups that already report increased occurrence of IPV may be 
placed at further risk during this crisis. The lifetime risk of IPV for transgender people is estimated at 31-
50% (20). COVID-19 may further increase this risk in a community that already has difficulty in 
accessing help and is underrepresented in data. The emotional, psychological, and physical burdens of a 
pandemic can negatively impact population wellbeing and increase need for mental health and 
psychosocial support. However, gendered differences in mortality, exposure to violence, and experiences 
of frontline health workers may alter the distribution of this burden and need for supportive services (10, 
13, 16).  
If sexual and reproductive health (SRH) resources are redirected for other emergency measures, this can 
further restrict access to essential resources (e.g., contraceptives, termination services) (5, 10, 15, 21). 
This is especially relevant in settings that already have difficulty ensuring these services (14). In past 
 
outbreaks, strained access to SRH care has contributed to increased child and maternal mortality (22). 
During the 2014-2015 Ebola outbreak, delays in care for pregnancy complications resulted in increased 
spontaneous abortions and hemorrhaging, among other negative outcomes (14). Supply chains for SRH 
and other hygiene items (e.g., menstrual health and hygiene management) can also be impeded during 
pandemics (10, 16). Accessibility of information on disease and prevention can differ by gender, related 
to literacy, educational attainment, internet access, and cell-phone ownership (12, 16). Rapid surveys 
from the UN have reported that women in Bangladesh and Pakistan are less likely to receive information 
about COVID-19 compared to men (16).  
There have been many commentaries and perspective pieces on the gendered effects of COVID-19 and its 
response. Research and data are quickly being generated to inform policies, as well as social and health 
services, to address these differential impacts. Several online resources, such as the UN Women’s Data 
Hub, Global Health 50/50, Data2X, and the Gender and COVID-19 Working Group from John Hopkins 
University, have worked to curate data and literature related to gender and sex during this pandemic. 
However, no collective synthesis of the current data has been done. In this review, we seek to understand 
available gender- and sex-disaggregated data and integrate current studies on the multisectoral impacts of 
COVID-19. By compiling and evaluating this information in one resource, we aim to create a resource 
that can be utilized by multiple disciplines and decisionmakers, periodically updated as evidence emerges, 
and referenced for insight on future policies and research in promoting health and gender equity.  
OBJECTIVE 
In this review, we will assess and synthesize currently available literature and data on the gender and sex 
differences of COVID-19, as well as impacts of this disease and its response measures across multiple 
outcomes, including health, social, economic, wealth, and education.   
In evaluating this body of evidence, we aim to present findings that can be of use across multiple 
disciplines, identify current gaps in research, and identify priority interventions.  
METHODS 
Selection Criteria 
We will be selecting peer-reviewed publications of secondary data analyses and primary quantitative, 
qualitative, and mixed methods research. Clinical studies and case reports in peer-reviewed journals on 
symptoms, treatment response, and hospitalizations will be included if data is gender- or sex-
disaggregated. We will not be including studies or reports involving treatment with hydroxychloroquine. 
Due to the multidisciplinary lens of this review, we will also include published working papers in the 
selection process. Commentaries and perspective pieces will be excluded.  
Publications must be COVID-19 specific and so, based on the timeline of this disease, publications prior 
to 2019 will be automatically excluded. Studies will not be limited based on language. Participants will 
consist of individuals of any gender, in all settings and across all ages, with no limitations on location or 
other demographic information.  
Outcomes of Interest  
This review will be focusing on the gendered impacts of COVID-19 across health, economic, and social 
factors. Outcomes of interest include but are not limited to: 
 
• Mortality  
• Morbidity  
• Risk of disease exposure  
• Hospitalization 
• Treatment response  
• Reproductive health outcomes 
• Exposure to violence 
• Economic insecurity  
• Disruption of education  
• Psychosocial and mental health needs 
 
Search Strategy 
Our search will be conducted using the following electronic databases: PubMed/Medline, CENTRAL, 
PsycINFO, and Google Scholar. We will perform a hand search of sex-disaggregated data found in the 
Global Heath 50/50 database, and resources compiled by the Gender and COVID-19 Working Group 
from John Hopkins University. In addition, we will hand search reference lists from selected studies and 
systematic reviews identified in our search for other potentially eligible literature. Dates of studies will be 
constrained to 2019 and onwards based on emergence of COVID-19. Search terms may be modified as 
the body of evidence on COVID-19 grows (see table 1 for a draft of search terms).  
Table 1. Key search terms  
covid-19 or 
coronavirus or 
CoV or 
SARS-CoV-2 or 
“covid-19 response*” or  
“coronavirus response*” or 
“SARS-CoV-2 response*” 
AND sex or gender or wom!n* or m!n* or transgender or male or 
female or “sex-disaggregated” or “gender-disaggregated” or 
“gender analys*” or “gender equity” or  “health equity” 
“gender-based violence” or GBV or  
“intimate partner violence” or IPV or “domestic violence” 
“psychosocial” or  “mental health” or “stress” 
“treatment” or “symptom*” or “mortality” or “morbidity” 
“hospitalization” or  “clinical management” “clinical outcomes” 
or “exposure risk”  
“economic securit*” or “economic status” or  
“income loss” or “income securit*” or “job security*” or 
“wealth”  
“school closure*” or “education* disruption” 
 
Methods for Selection 
Once potential studies are identified from the above search and any duplicate articles are removed, the 
residual titles and abstracts will be evaluated for relevance to our objective. We will obtain the full-texts 
of all potentially eligible studies, corresponding with study researchers when necessary. All decisions for 
selecting or excluding studies will be documented and outlined using a PRISMA diagram.   
Data Extraction  
Screening and data extraction will be performed by one reviewer, who will consult with a second 
reviewer based on concerns or deliberations. Disagreements will be resolved through discussion. Any 
 
gender- or sex-disaggregated data related to our outcomes of interest from selected studies will be 
collected. We will also extract data related to research design, location, participant characteristics, and 
other key study features.  
Assessing Study Quality 
Clinical, epidemiological and social science research studies will be evaluated and categorized as high, 
medium, or low quality based on the following criteria:  
1. Clear research question(s) 
2. Research methods consistent with standard practices  
3. Sample size and justification  
4. Appropriate analytic methods to answer research question(s)  
5. Recommendations are clearly made based on analysis and findings from study  
Studies will be considered high quality if they meet 4-5 of the above criteria, medium quality if they meet 
3, and low quality if they meet 2 or less. Clinical case reports and communications will be exempt from 
quality assessment based on the novel nature of COVID-19.  
Data Analysis and Synthesis  
We will present outcomes and relevant findings from selected studies using descriptive synthesis, noting 
common themes and recommendations from included literature. We will also be noting apparent gaps and 
ongoing needs in research, based on outcomes that are and are not being assessed in the selected articles. 
Our study limitations include a potential lack of uniformity for included methodology and outcome 
measures, given the broad nature of our objective. 
RESULTS  
Proposed Tables and Figures 
Figure 1. Outline of study selection for literature review on the health, economic, and social effects of 
COVID-19 on gender and sex (adapted PRISMA flow diagram) 
Sample Table 2. Overview and characteristics of included studies 
Study Country/Region Participants & 
Methods 
N Study Quality 
 
Sample Table 3. Summary of included studies with outcomes assessed and description of relevant 
findings related to COVID-19 and gender 
Study Outcomes  Relevant Findings 
 
Sample Figure 2. Distribution of outcomes of interest across selected studies on COVID-19 with gender- 
and sex-disaggregated data 
  
IMPLICATIONS  
Gender continues to be a crucial influence in health, economic, and social outcomes. Global emergencies, 
like COVID-19, threaten to exacerbate and perpetuate gender inequalities, and require a gender lens for 
equitable response and interventions. This review synthesizes currently available gender- and sex-
disaggregated data and evidence on COVID-19 and its impacts. We aim to periodically update this review 
as evidence continues to emerge. These results will have implications for policy recommendations and 
ongoing research in identifying priority issues, what gaps in knowledge remain, and recommendations for 
promoting health and gender equity in the midst and aftermath of COVID-19.  
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